Methodologic considerations in treatment using intraperitoneal chemotherapy

Cancer Treat Res. 1996;82:289-309. doi: 10.1007/978-1-4613-1247-5_18.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacokinetics
  • Drug Delivery Systems
  • Female
  • Humans
  • Neoplasms / drug therapy*
  • Ovarian Neoplasms / drug therapy
  • Peritoneal Cavity
  • Peritoneal Neoplasms / drug therapy

Substances

  • Antineoplastic Agents